{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for amphotericin root_notes_note in Note (approximate match)
Sodium fluoroborate (sodium tetrafluoroborate) is an inorganic compound with the formula NaBF4. It is used in the sand casting of aluminum, electrochemical processes, and as fluorinating agent. It is also used as an additive in chrome, nickel and cadmium plating baths. Sodium tetrafluoroborate may be used as a catalyst for the synthesis of bis(indolyl)methanes via electrophilic substitution reaction of indoles with aldehydes and ketones. It may also be used as a source of tetrafluoroborate anoins during the synthesis of ionic liquids like 1-butyl-3-methylimidazolium tetrafluoroborate[4] and trihexyl(tetradecyl)phosphonium tetrafluoroborate.
Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)
Status:
Other
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
Milk thistle (Silybum marianum) has been used for centuries for the treatment of liver disorders and as a hepatoprotectant. The primary extract of milk thistle is termed silymarin, a complex mixture that contains a number of structurally-related flavonolignans, the flavonoid, taxifolin, and a number of other constituents. The major flavonolignans present in most extracts are silybin A, silybin B, isosilybin A and isosilybin B, silydianin, silychristin and isosilychristin. Isosilybin B elicited the strongest anti-NF-kappaB and anti-HCV actions. The data suggest that silymarin-derived compounds may influence HCV disease course in some patients. Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway.